KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $7.3 million.

  • Vertex Pharmaceuticals' Exchange Rate Effect rose 11543.34% to $7.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $90.9 million, marking a year-over-year increase of 31338.03%. This contributed to the annual value of $90.9 million for FY2025, which is 31338.03% up from last year.
  • According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Exchange Rate Effect is $7.3 million, which was up 11543.34% from -$4.1 million recorded in Q3 2025.
  • Vertex Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $57.2 million during Q2 2025, with a 5-year trough of -$47.3 million in Q4 2024.
  • For the 5-year period, Vertex Pharmaceuticals' Exchange Rate Effect averaged around $1.6 million, with its median value being -$3.2 million (2021).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 74750.0% in 2022, then skyrocketed by 238800.0% in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Exchange Rate Effect stood at -$4.9 million in 2021, then surged by 932.65% to $40.8 million in 2022, then tumbled by 32.84% to $27.4 million in 2023, then tumbled by 272.63% to -$47.3 million in 2024, then surged by 115.43% to $7.3 million in 2025.
  • Its Exchange Rate Effect stands at $7.3 million for Q4 2025, versus -$4.1 million for Q3 2025 and $57.2 million for Q2 2025.